Healthcare expenditure

The Government and Farmaindustria renew the Agreement for Sustainability, Access and Innovation

The Agreement, which will remain in effect throughout 2018, aims to facilitate patient access to therapeutic innovations under equitable conditions and ensure the sustainability of the National Health System

Monthly Bulletin 128

Download document

Evolution of Spanish public pharmaceutical expenditure

Download document

Spain, above the European average in clinical trials in oncology

The excellence of the professionals, the quality of the National Health System, the commitment of the industry and the new legal framework, facilitate the clinical research against cancer in Spain

The improvement of the medicines ensures that the healthcare cost of the cancer treatment remains stable despite the increase in the incidence rates

The Government and FARMAINDUSTRIA renew the Agreement for Sustainability, Access and Innovation

The agreement is the result of a sustained dialogue and positive experience from the Protocol signed in 2015 and will be in force throughout 2017

Healthcare professionals, patients and industry present a plan to improve adherence to treatment

Technical proposal to health authorities to combat the high rate of therapeutic non-compliance and its effects on health

EFPIA – The Pharmaceutical Industry in Figures 2016

FormatPDF  - Size4Mb
Download document

FARMAINDUSTRIA ratifies its commitment with sustainability and access to innovations before the King of Spain.

His Majesty King Felipe VI hosted an audience with Farmaindustria’s Board of Directors

EFPIA report on BREXIT consequences: Assessing the impact on the life sciences industry of a change in the UK relationship with the EU

Download document

Monthly Bulletin 127

Download document

© 2022 FarmaIndustria All rights reserved